Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial

Iron overload is a severe general complication of hereditary anemias. Treatment with iron chelators is hampered by important side‐effects, high costs, and the lack of availability in many countries with a high prevalence of hereditary anemias. In this phase III randomized placebo‐controlled trial, w...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vuren, Annelies, Kerkhoffs, Jean Louis, Schols, Saskia, Rijneveld, Anita, Nur, Erfan, Peereboom, Dore, Gandon, Yves, Welsing, Paco, van Wijk, Richard, Schutgens, Roger, van Solinge, Wouter, Marx, Joannes, Leiner, Tim, Biemond, Bart, van Beers, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325377/
https://www.ncbi.nlm.nih.gov/pubmed/35472008
http://dx.doi.org/10.1002/ajh.26581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325377/
https://www.ncbi.nlm.nih.gov/pubmed/35472008
http://dx.doi.org/10.1002/ajh.26581

Ejemplares similares